At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 20 enrolled
Drug / intervention
Tobramycin Powder +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Study Investigating Antibiotic Elution From Free Intra-articular Vancomycin and Tobramycin After Cementless Total Knee Arthroplasty
In Brief
A Phase 4 clinical trial evaluating Tobramycin Powder and Vancomyscin for Antibotics in Cementless Knees. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of the study is to determine the intra-articular concentration of vancomycin and tobramycin after administration of vancomycin and tobramycin powder in primary cementless total knee arthroplasty and determine the serum concentrations of these antibiotics postoperatively.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAntibotics in Cementless Knees
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
Enrollment StartFeb 2020
First PostedMar 2020
Primary CompletionAug 2020
Study CompletionNov 2020
TodayJul 2026
First PostedMar 5, 2020
Enrollment StartFeb 14, 2020
Primary CompletionAug 1, 2020
Study CompletionNov 1, 2020
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 6.3 years ago
Interventions
Tobramycin Powderdrug
Everyone gets tobramycin powder.
Vancomyscindevice
Everyone gets the vancomyscin powder.